Nation
World
Business
Politics
Opinion
Sports
Crime
Science
Tech
Health
Entertainment
Life
Oddities

BioNTech SE ADR rises Thursday, outperforms market

Por: MarketWatch Business January 22, 2021

thumbnail

Editor's Note: This story was auto-generated by using data from Dow Jones and FactSet.... + full article



Similar News

Pfizer, BioNTech boost vaccine output goal by more than 50%

The Boston Globe USA Business January 11, 2021

thumbnail(Bloomberg)— Pfizer and BioNTech plan to produce 2 billion doses of their COVID-19 vaccine this year, boosting previously expected output by more than 50 percent in response to surging global demand.The companies have already agreed to deliver more than 1 billion doses in... + más

Here are 5 things to know about BioNTech and the married couple behind the COVID-19 vaccine with Pfizer | MarketWatch

FDA advisers give thumbs up to Pfizer vaccine, paving way for authorization | Ars Technica


BioNTech SE ADR rises Friday, outperforms market

MarketWatch USA Business January 09, 2021

thumbnailThe ADR outperformed some of its competitors Friday, as AbbVie Inc. rose 0.52% to $107.27 and Amgen Inc. rose 1.91% to $238.49. Trading volume (4.0 M) remained 447,263 below its 50-day average volume of 4.4 M. Editor's Note: This story was auto-generated by using data from... + más

BioNTech SE ADR rises Thursday, outperforms market | MarketWatch

Here are 5 things to know about BioNTech and the married couple behind the COVID-19 vaccine with Pfizer | MarketWatch


BioNTech SE ADR rises Thursday, outperforms market

MarketWatch USA Business January 08, 2021

thumbnailThe ADR outperformed some of its competitors Thursday, as AbbVie Inc. rose 1.07% to $106.71 and Amgen Inc. rose 0.33% to $234.02. Trading volume (3.0 M) remained 1.4 million below its 50-day average volume of 4.4 M. Editor's Note: This story was auto-generated by using data... + más

Here are 5 things to know about BioNTech and the married couple behind the COVID-19 vaccine with Pfizer | MarketWatch

BioNTech SE ADR rises Friday, outperforms market | MarketWatch


Tesla Inc. stock rises Thursday, outperforms market

MarketWatch USA Business January 07, 2021

thumbnailThe stock outperformed some of its competitors Thursday, as Toyota Motor Corp. ADR fell 0.56% to $152.67, General Motors Co. rose 0.79% to $43.32, and Honda Motor Co. Ltd. ADR fell 0.25% to $28.17. Trading volume (49.6 M) eclipsed its 50-day average volume of 44.9 M.... + más

Tesla Is Joining the S&P 500. This Stock Is Coming Out. | MarketWatch

Tesla Is Joining the S&P 500. This Stock Is Coming Out. | MarketWatch


Tesla Inc. stock rises Monday, outperforms market

MarketWatch USA Business January 05, 2021

thumbnailThe stock outperformed some of its competitors Monday, as Toyota Motor Corp. ADR fell 0.83% to $153.29, General Motors Co. fell 2.71% to $40.51, and Honda Motor Co. Ltd. ADR fell 1.73% to $27.76. Trading volume (48.4 M) eclipsed its 50-day average volume of 43.9 M. Editor's... + más

Tesla Is Joining the S&P 500. This Stock Is Coming Out. | MarketWatch

Tesla Is Joining the S&P 500. This Stock Is Coming Out. | MarketWatch


Tesla Inc. stock rises Monday, outperforms market

MarketWatch USA Business December 08, 2020

The stock outperformed some of its competitors Monday, as Toyota Motor Corp. ADR fell 0.09% to $138.15, General Motors Co. fell 0.20% to $44.31, and Honda Motor Co. Ltd. ADR fell 1.23% to $29.81. Trading volume (55.1 M) eclipsed its 50-day average volume of 38.5 M. Editor's... + más

Tesla Is Joining the S&P 500. This Stock Is Coming Out. | MarketWatch

Tesla Is Joining the S&P 500. This Stock Is Coming Out. | MarketWatch


Here are 5 things to know about BioNTech and the married couple behind the COVID-19 vaccine with Pfizer

MarketWatch USA Politics December 04, 2020

Shares in BioNTech have soared more than 257% year-to-date . Its vaccine candidate, developed in partnership with U.S. drugmaker Pfizer , was granted emergency-use on Wednesday, the first country to give approval. The rollout is set to begin next week, with people over the age... + más

First COVID-19 vaccine receives emergency-use authorization from U.S. FDA | MarketWatch

The timeline for vaccine approval around the world, as U.K. authorizes COVID-19 shot | MarketWatch



About iurex | Privacy Policy | Descargo de Responsabilidad |